Johnson & Johnson MedTech announced positive three-month results from a study evaluating its investigational Omnypulse platform.

The FDA’s head during the Biden administration, Dr. Robert Califf, repeatedly said that the agency’s current regulatory model, in which approved devices are generally not scrutinized again, doesn’t ...

Michael Hoey admits he’s terrible at names. He used to call his kids “One, Two and Three.” When naming his startup seeking to ...

Multinational healthcare company Johnson & Johnson (NYSE:JNJ) in Q1 CY2025, with sales up 2.4% year on year to $21.89 billion ...

HSBC has reshuffled its ratings across the MedTech and Life Sciences sector, upgrading Siemens Healthineers AG (ETR:SHLG) and Sonova (SIX:SOON) to Buy while cutting Align Technology (NASDAQ:ALGN), ...

Umvuzo Health celebrates 21 years with AI-powered wearables, DNA testing, and gut microbiome analytics—offering a bold new ...

For the first quarter of this year, J&J’s total sales of $21.9 billion were up 4.2% over the start of 2024, when accounting ...

The company joins Johnson & Johnson and Abbott as top medtech firms that expect an impact in the hundreds of millions of ...

Trump administration policies have raised questions about how the FDA will regulate AI in medical devices. AdvaMed board ...

Johnson & Johnson MedTech reported that it has completed the first U.S. clinical cases of its Ottava surgical robot, with a ...

Clarivate Plc (NYSE: CLVT), a leading global provider of transformative intelligence, today announced the launch of DRG ...